1. Ahn, B. and Ohshima, H. (2001). Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res. 61(23), 8357–8360.
2. Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Harrington, A.M., Shields, P.G., Felley-Bosco, E., Hussain, S.P., and Harris, C.C. (1999). Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst. 6, 91(1), 86–88.
3. Ambs, S., Merriam, W.G., Bennett, W.P., Felley-Bosco, E., Ogunfusika, M.O., Oser, S.M., Klein, S., Shields, P.G., Billiar, T.R., and Harris, C.C. (1998a). Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58(2), 334–341.
4. Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Khan, M.A., Jones, R.T., and Harris, C.C. (1998b). Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br. J. Cancer 78(2), 233–239.
5. Ambs, S., Merriam, W.G., Ogunfusika, M.O., Bennett, W.P., Ishibe, N., Hussain, S.P., Tzeng, E.E., Geller, D.A., Billiar, T.R., and Harris, C.C. (1998c). p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat. Med. 4(12), 1371–1376.